Editas Medicine (NASDAQ:EDIT) PT Lowered to $7.00 at Evercore ISI
Editas Medicine (NASDAQ:EDIT – Free Report) had its target price decreased by Evercore ISI from $15.00 to $7.00 in a report issued on Thursday morning, MarketBeat Ratings reports. Evercore ISI currently has an in-line rating on the stock. Several other research firms have also issued reports on EDIT. JPMorgan Chase & Co. raised their price […]
More Stories
Great Western Mining (LON:GWMO) Hits New 52-Week Low – Here’s Why
Shares of Great Western Mining Co. PLC (LON:GWMO – Get Free Report) reached a new 52-week low on Tuesday ....
Chakana Copper (CVE:PERU) Shares Down 28.6% – Here’s What Happened
Chakana Copper Corp. (CVE:PERU – Get Free Report)’s stock price traded down 28.6% during trading on Tuesday . The stock...
Basic Attention Token Price Tops $0.16 on Major Exchanges (BAT)
Basic Attention Token (BAT) traded 2.1% lower against the US dollar during the one day period ending at 16:00 PM...
Flare Price Hits $0.0141 on Major Exchanges (FLR)
Flare (FLR) traded down 2.4% against the dollar during the 24-hour period ending at 16:00 PM Eastern on October 10th....
Protalex (OTCMKTS:PRTX) versus bioAffinity Technologies (NASDAQ:BIAF) Financial Analysis
bioAffinity Technologies (NASDAQ:BIAF – Get Free Report) and Protalex (OTCMKTS:PRTX – Get Free Report) are both medical companies, but which...
SmarDex Price Hits $0.0079 on Top Exchanges (SDEX)
SmarDex (SDEX) traded down 4.3% against the U.S. dollar during the 24 hour period ending at 16:00 PM ET on...